AMN HEALTHCARE SERVICES INC
Business
AMN Healthcare Services Inc provides total talent solutions that connect healthcare organizations with a national network of qualified healthcare professionals. The company offers staffing and recruitment for nurses, physicians, allied health professionals, interim and executive leadership, locum tenens, language interpretation, revenue cycle services, and technology-enabled workforce optimization and scheduling solutions. Its operations are organized into nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions reportable segments. AMN primarily serves healthcare clients across the United States through direct staffing, managed services, vendor management systems, and SaaS channels.
Summary from filing dated 2025-02-21
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 2,730 | 2,984 | 3,789 | 5,243 | 3,984 | |
| Cost of revenue | 1,956 | 2,064 | 2,540 | 3,527 | 2,675 | |
| Gross profit | 774 | 919 | 1,250 | 1,717 | 1,310 | |
| Selling, general and administrative | 593 | 632 | 748 | 937 | 730 | |
| Depreciation and amortization (exclusive of depreciation included in cost of revenue) | 148 | 167 | 155 | 133 | 101 | |
| Gain on sale of disposal group | −39 | 0 | 0 | — | — | |
| Goodwill impairment losses | 110 | 222 | 0 | 0 | — | |
| Long-lived assets impairment losses | 18 | 0 | 8 | — | — | |
| Total operating expenses | 830 | 1,022 | 911 | 1,070 | 832 | |
| Income (loss) from operations | −55 | −103 | 338 | 647 | 478 | |
| Interest expense, net, and other | 46 | 70 | 54 | 40 | — | |
| Income (loss) before income taxes | −101 | −173 | 284 | 607 | 444 | |
| Income tax expense (benefit) | −5 | −26 | 74 | 163 | 117 | |
| Net income (loss) | −96 | −147 | 211 | 444 | 327 | |
| Unrealized gains on available-for-sale securities, net, and other | 309,000 | 412,000 | 516,000 | −644,000 | −335,000 | |
| Other comprehensive income | 309,000 | 412,000 | 516,000 | −644,000 | −335,000 | |
| Comprehensive income (loss) | −95 | −147 | 211 | 443 | 327 | |
| Basic (in dollars per share) | −2.48 | −3.85 | 5.38 | 9.96 | 6.87 | |
| Diluted (in dollars per share) | −2.48 | −3.85 | 5.36 | 9.9 | 6.81 | |
| Basic (in shares) | 39 | 38 | 39 | 45 | 48 | |
| Diluted (in shares) | 39 | 38 | 39 | 45 | 48 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 34 | 11 | 33 | 65 | 181 | |
| Accounts receivable, net of allowances of $16,580 and $32,421 at December 31, 2025 and 2024, respectively | 383 | 438 | 623 | 676 | 789 | |
| Accounts receivable, subcontractor | 48 | 70 | 118 | 269 | — | |
| Prepaid expenses | 21 | 23 | 22 | 19 | 72 | |
| Other current assets | 60 | 53 | 46 | 66 | 67 | |
| Total current assets | 545 | 595 | 842 | 1,094 | 1,349 | |
| Restricted cash, cash equivalents and investments | 46 | 72 | 69 | 61 | 64 | |
| Fixed assets, net of accumulated depreciation of $414,797 and $360,795 at December 31, 2025 and 2024, respectively | 136 | 186 | 191 | 149 | 127 | |
| Other assets | 283 | 258 | 237 | 172 | 157 | |
| Deferred income taxes, net | 45 | 26 | 0 | — | — | |
| Goodwill | 756 | 897 | 1,112 | 935 | 892 | |
| Intangible assets, net of accumulated amortization of $561,590 and $534,822 at December 31, 2025 and 2024, respectively | 284 | 381 | 474 | 477 | 514 | |
| Total assets | 2,094 | 2,416 | 2,924 | 2,888 | 3,132 | |
| Accounts payable and accrued expenses | 162 | 184 | 344 | 476 | 425 | |
| Accrued compensation and benefits | 299 | 288 | 279 | 333 | 354 | |
| Other current liabilities | 117 | 74 | 34 | 48 | 162 | |
| Total current liabilities | 578 | 546 | 656 | 858 | 969 | |
| Revolving credit facility | 25 | 210 | 460 | 0 | — | |
| Notes payable, net of unamortized fees and premium | 742 | 846 | 845 | 844 | 842 | |
| Other long-term liabilities | 107 | 107 | 109 | 121 | 97 | |
| Total liabilities | 1,452 | 1,709 | 2,093 | 1,845 | 1,970 | |
| Commitments and contingencies | — | — | — | — | — | |
| Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at December 31, 2025 and 2024 | 0 | 0 | 0 | 0 | 0 | |
| Common stock, $0.01 par value; 200,000 shares authorized; 51,054 issued and 38,441 outstanding at December 31, 2025 and 50,692 issued and 38,079 outstanding at December 31, 2024 | 511,000 | 507,000 | 504,000 | 501,000 | 498,000 | |
| Additional paid-in capital | 559 | 528 | 507 | 502 | 487 | |
| Treasury stock, at cost; 12,613 shares at December 31, 2025 and 2024 | −1,127 | −1,127 | −1,127 | −699 | −122 | |
| Retained earnings | 1,209 | 1,305 | 1,452 | 1,241 | 797 | |
| Accumulated other comprehensive income (loss) | 298,000 | −11,000 | −423,000 | −939,000 | −295,000 | |
| Total stockholders equity | 642 | 707 | 831 | 1,044 | 1,162 | |
| Total liabilities and stockholders equity | 2,094 | 2,416 | 2,924 | 2,888 | 3,132 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization (inclusive of depreciation included in cost of revenue) | 157 | 174 | 161 | 137 | 104 | |
| Non-cash interest expense and other | 3 | 12 | 9 | 5 | −4 | |
| Write-off of fees on credit facilities and senior notes | 1 | 0 | 0 | 0 | 158,000 | |
| Change in fair value of contingent consideration liabilities | 0 | 0 | 2 | −3 | 0 | |
| Increase in allowance for credit losses and sales credits | 2 | 3 | 24 | 58 | 6 | |
| Provision for deferred income taxes | −20 | −51 | −13 | −25 | −16 | |
| Share-based compensation | 31 | 23 | 18 | 30 | 25 | |
| Net loss (gain) on deferred compensation balances | 2 | −1 | 465,000 | −526,000 | 20,000 | |
| Loss on disposal or impairment of long-lived assets | 18 | 65,000 | 8 | 2 | 3 | |
| Net loss (gain) on investments in available-for-sale securities | −106,000 | 200,000 | 302,000 | 749,000 | −52,000 | |
| Non-cash lease expense | −708,000 | −1 | 2 | 5 | 4 | |
| Accounts receivable | 49 | 176 | 70 | 58 | −420 | |
| Accounts receivable, subcontractor | 22 | 47 | 151 | — | — | |
| Income taxes receivable | 3 | −4 | 4 | −9 | 7 | |
| Prepaid expenses | 2 | −2 | −2 | 54 | −59 | |
| Other current assets | −3 | −9 | 4 | 18 | −22 | |
| Other assets | 5 | 87,000 | −3 | 210,000 | 3 | |
| Accounts payable and accrued expenses | −21 | −155 | −184 | 49 | 256 | |
| Accrued compensation and benefits | −12 | −11 | −80 | −11 | 129 | |
| Other liabilities | 49 | 44 | −10 | −127 | 123 | |
| Deferred revenue | 6 | −1 | −558,000 | −4 | 4 | |
| Net cash provided by operating activities | 269 | 320 | 372 | 654 | 305 | |
| Purchase and development of fixed assets | −36 | −81 | −104 | −76 | −54 | |
| Purchase of investments | −36 | −1 | 0 | −13 | −61 | |
| Proceeds from sale and maturity of investments | 11 | 9 | 10 | 14 | 58 | |
| Proceeds from sale of disposal group | 65 | 0 | 0 | — | — | |
| Proceeds from sale of equity investment | 0 | 0 | 77,000 | 68,000 | 78,000 | |
| Payments to fund deferred compensation plan | −6 | −8 | −25 | −22 | −8 | |
| Proceeds from settlements of company-owned life insurance policies | 6 | 0 | 0 | — | — | |
| Cash paid for acquisitions, net of cash and restricted cash received | 0 | 0 | −292 | −70 | −41 | |
| Cash paid for other intangibles | 0 | 0 | −2 | −5 | −90,000 | |
| Cash received for working capital settlement of prior year acquisition | 0 | 2 | 0 | 0 | — | |
| Net cash provided by (used in) investing activities | 4 | −80 | −412 | −171 | −107 | |
| Payments on revolving credit facility | −315 | −375 | −355 | 0 | −70 | |
| Proceeds from revolving credit facility | 130 | 125 | 815 | 0 | 70 | |
| Proceeds from senior notes | 400 | 0 | 0 | 0 | 0 | |
| Redemption of senior notes | −500 | 0 | 0 | 0 | 0 | |
| Payments on loans payable | 0 | 0 | −300,000 | 0 | 0 | |
| Repurchase of common stock | 0 | 0 | −425 | −577 | −3 | |
| Payment of excise tax on share repurchases | 0 | −4 | 0 | 0 | — | |
| Payment of financing costs | −9 | −973,000 | −4 | 0 | 0 | |
| Earn-out payments to settle contingent consideration liabilities for prior acquisitions | 0 | 0 | −8 | 0 | −3 | |
| Cash paid for shares withheld for taxes | −2 | −5 | −13 | −15 | −7 | |
| Net cash provided by (used in) financing activities | −296 | −259 | 11 | −592 | −35 | |
| Net decrease in cash, cash equivalents and restricted cash | −22 | −19 | −30 | −109 | 163 | |
| Cash paid for amounts included in the measurement of operating lease liabilities | 9 | 10 | 9 | 13 | 40 | |
| Cash paid for interest (net of $229, $606 and $1,229 capitalized in 2025, 2024 and 2023, respectively) | 45 | 61 | 48 | 38 | 38 | |
| Cash paid for income taxes | 8 | 28 | 78 | 214 | 106 | |
| Fair value of tangible assets acquired in acquisitions, net of cash and restricted cash received | 0 | 0 | 49 | 3 | 2 | |
| Goodwill | 0 | 0 | 176 | 43 | 27 | |
| Intangible assets | 0 | 0 | 92 | 40 | 12 | |
| Liabilities assumed | 0 | 0 | −25 | −8 | −275,000 | |
| Purchase of fixed assets recorded in accounts payable and accrued expenses | 2 | 3 | 8 | 6 | 4 | |
| Excise tax payable on share repurchases | 0 | 0 | 4 | 0 | 0 | |
| Right-of-use assets obtained in exchange for operating lease liabilities | 1 | 5 | 37 | 6 | 3 |